CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report)’s stock price shot up 0.9% during mid-day trading on Wednesday . The company traded as high as C$4.08 and last traded at C$4.08. 522 shares changed hands during trading, a decline of 85% from the average daily volume of 3,545 shares. The stock had previously closed at C$4.04.
CSPC Pharmaceutical Group Stock Performance
The business has a fifty day moving average of C$3.79 and a 200-day moving average of C$4.41.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
Featured Stories
- Five stocks we like better than CSPC Pharmaceutical Group
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
